Medinotec Inc Quick Ratio (MDNC) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Medinotec Inc   (MDNC)

Medinotec Inc 's Quick Ratio

MDNC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Medinotec Inc 's Cash & cash equivalent grew by 2.59 % in the Q2 2026 sequentially, while Current Liabilities decreased, this led to improvement in Medinotec Inc 's Quick Ratio to 2.68, Quick Ratio remained below Medinotec Inc average.

Within Medical Equipment & Supplies industry 67 other companies have achieved higher Quick Ratio than Medinotec Inc in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 1260, from total ranking in the first quarter 2026 at 1761.

Explain Quick Ratio?
How much Cash & cash equivalents MDNC´s has?
What are MDNC´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/MDNC/financial-strength
https://api.csimarket.com/api/v1/companies/MDNC/fundamentals
https://api.csimarket.com/api/v1/companies/MDNC/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
MDNC Quick Ratio (Aug 31 2026)
Q2
(May 31 2026)
Q1
(Feb 28 2026)
Q4
(Nov 30 2025)
Q3
(Aug 31 2025)
Q2
Y / Y Current Liabilities Change -36.02 %
Y / Y Cash & cash equivalent Change 14.95 %
Quick Ratio MRQ 2.68
MDNC's Total Ranking # 1260
Seq. Current Liabilities Change -17.73 %
Seq. Cash & cash equivalent Change 2.59 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 68
Healthcare Sector # 428
Overall Market # 1199


Quick Ratio Statistics
High Average Low
36.11 7.74 0.6
(Feb 28 2023)   (Feb 28 2022)




Financial Statements
Medinotec Inc 's Current Liabilities $ 1 Millions Visit MDNC's Balance sheet
Medinotec Inc 's Cash & cash equivalent $ 3 Millions Visit MDNC's Balance sheet
Source of MDNC's Sales Visit MDNC's Sales by Geography


Cumulative Medinotec Inc 's Quick Ratio

MDNC's Quick Ratio for the trailling 12 Months

MDNC Quick Ratio

(Aug 31 2026)
12 Months
(May 31 2026)
12 Months
(Feb 28 2026)
12 Months
(Nov 30 2025)
12 Months
(Aug 31 2025)
12 Months
Y / Y Current Liabilities TTM Growth -27.65 %
Y / Y Cash & cash equivalent TTM Growth 11.11 %
Quick Ratio TTM 2.27
Total Ranking TTM # 923
Seq. Current Liabilities TTM Growth -10.31 %
Seq. Cash & cash equivalent TTM Growth 3.24 %


On the trailing twelve months basis MDNC Cash & cash equivalent increased by 14.95 % in Q2 2026 year on year, while Current Liabilities faded to $1 millions, this led to increase in in Medinotec Inc 's Quick Ratio to 2.27, Quick Ratio remained below MDNC average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 198 other companies have achieved higher Quick Ratio than Medinotec Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 3868.

Explain Quick Ratio?
How much Cash & cash equivalents MDNC´s has?
What are MDNC´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 199
Healthcare Sector # 880
Within the Market #


trailing twelve months Quick Ratio Statistics
High Average Low
6.2 2.57 1.47
(Feb 29 2024)   (Nov 30 2025)




Companies with similar Quick Ratio in the quarter ending Aug 31 2026, within Medical Equipment & Supplies Industry Quick RatioAug 31 2026 MRQ Cash & cash equivalentAug 31 2026 MRQ Current Liabilities
Envveno Medical Corporation  7.13 $ 18.472  Millions$ 2.589  Millions
Ceribell Inc   6.51 $ 117.467  Millions$ 18.034  Millions
Iradimed Corporation  6.13 $ 63.288  Millions$ 10.323  Millions
Perspective Therapeutics Inc   5.09 $ 201.695  Millions$ 39.602  Millions
Clearpoint Neuro Inc   4.68 $ 46.184  Millions$ 9.869  Millions
Cvrx inc   4.67 $ 58.746  Millions$ 12.583  Millions
Dexcom Inc   4.25 $ 964.800  Millions$ 227.000  Millions
Innovative Eyewear Inc   3.86 $ 3.197  Millions$ 0.829  Millions
Sight Sciences Inc   3.84 $ 77.402  Millions$ 20.137  Millions
Profound Medical Corp   3.41 $ 33.343  Millions$ 9.771  Millions
Rxsight Inc   3.40 $ 254.683  Millions$ 74.952  Millions
Omada Health Inc   3.23 $ 243.151  Millions$ 75.379  Millions
Transmedics Group Inc   3.22 $ 492.962  Millions$ 152.857  Millions
Procept Biorobotics Corporation  3.10 $ 218.369  Millions$ 70.353  Millions
Outset Medical Inc   3.07 $ 136.627  Millions$ 44.453  Millions
Sharps Technology Inc   2.82 $ 7.478  Millions$ 2.650  Millions
Edwards Lifesciences Corporation  2.81 $ 4,683.700  Millions$ 1,664.300  Millions
Mimedx Group Inc   2.81 $ 120.791  Millions$ 43.031  Millions
Pulse Biosciences Inc   2.74 $ 36.725  Millions$ 13.395  Millions
Staar Surgical Co  2.73 $ 206.414  Millions$ 75.541  Millions
Medinotec Inc   2.68 $ 2.584  Millions$ 0.963  Millions
Glaukos Corp  2.66 $ 337.478  Millions$ 126.726  Millions
Pulmonx Corporation  2.57 $ 53.245  Millions$ 20.739  Millions
Beta Bionics Inc   2.48 $ 81.551  Millions$ 32.836  Millions
Irhythm Holdings Inc   2.46 $ 560.719  Millions$ 228.025  Millions
Genedx Holdings Corp   2.38 $ 170.118  Millions$ 71.403  Millions
Apyx Medical Corp  2.37 $ 25.777  Millions$ 10.870  Millions
Atricure Inc   2.23 $ 187.031  Millions$ 83.972  Millions
Inspire Medical Systems inc   1.96 $ 190.803  Millions$ 97.438  Millions
Merit Medical Systems Inc  1.90 $ 503.551  Millions$ 265.083  Millions

Date modified: 2026-10-09T04:24:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.